Pfizer Vaccine News Improving Market Outlook for Half of Investors

This week’s Sentiment Survey special question asked AAII members how the news about Pfizer’s coronavirus vaccine has impacted their outlook for stocks.

Nearly half (48%) of respondents say that Pfizer’s coronavirus vaccine has improved their outlook for stocks. This compares to about 45% of respondents who say that it has little to no impact on their outlook for stocks.

Here is a sampling of the responses:

• “It has reduced the magnitude of my projected downward, but relentless, pressure on stock prices.”
• “I feel better in the very near term, but the coronavirus remains very worrisome for the late fall and winter. Unfortunately, the political transition will not go smoothly which will also add to volatility. I think we will see ups and downs in the markets where overall we stay about even.”
• “Pfizer’s news about a vaccine has given me a little tempered optimism, but we are far from being out of the woods with the coronavirus.”
• “It does not change my neutral to bearish outlook much. Even with a vaccine, there are still serious uncertainties about accessibility and availability of the vaccine to those who require it.”

If you want to become an effective manager of your own assets and achieve your financial goals, consider a risk-free 30-day Trial AAII Membership